Pfizer. Working Together for a Healthier WorldTM
At Pfizer, we apply science and our global resources to bring therapies that extend and significantly improve lives..
For more than 150 years, Pfizer has worked to make a difference for all who rely on us. Answering the World Health Organization’s call to end trachoma, we partnered with the International Trachoma Initiative and committed to donate our antibiotic for the treatment of those at risk for this neglected tropical disease. Over almost twenty years we have donated 500 million doses through this profoundly impactful collaboration with ITI. Pfizer has been actively collaborating with APGC and had supported development of APGC 2016 guidelines.
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical leader. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories.
Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry.
Allergan’s success is powered by our global colleagues’ commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.
With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.
For more information, visit Allergan’s website at www.Allergan.com.
pH Pharma’s vision is to discover and develop distinctive and innovative healthcare technologies and therapies. Our therapeutic candidates in clinical development target Glaucoma (PHP-201, ROCK inhibitor) and Metabolic syndromes. pH Pharma was founded in 2015 and is headquartered in Seoul, Korea with a main Silicon Valley office in California.
Asia Pacific Academy of Ophthalmology (APAO)
The Asia-Pacific Academy of Ophthalmology (APAO) is a nonprofit organization composed of ophthalmic associations from the Asia-Pacific region. Since its founding in 1960, APAO has worked to promote the development of eye care services, prevention of blindness and exchange of scientific ideas through the APAO Congress and other key initiatives.
CenterVue designs and manufactures high-technological diagnostic systems for the early detection and the management of sight-threatening pathologies, such as Diabetic Retinopathy, Macular Degeneration and Glaucoma.
Our goal is to offer user-friendly devices that allow eye practitioners to preserve patients’ sight and quality of vision, in particular by detecting preventable disease.
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma. Flagship products, the iStent® and iStent inject®, are designed to reduce IOP and dependence on ocular hypotensive medications in patients with mild-to-moderate open-angle glaucoma.
We are thinking of the human Health and the Future.With the responsible mission that Hanlim’s products are directly linked with public health, we are exerting our utmost efforts in realizing a healthy society, under the spirit of respect for life.
Heidelberg Engineering is an imaging solutions company which designs, manufactures, and distributes diagnostic instruments for eye care professionals to scan patients’ eyes for signs of disease and to assist in the management of those with diagnosed diseases. Our core technologies include confocal microscopy, scanning lasers, OCT and related IT solutions.
Icare is the original developer of the rebound technique for tonometry. The Icare product line offers a range of handheld devices for accurate, consistent and reproducible measurement of intraocular pressure in virtually any circumstances.
IRIDEX is a worldwide provider of laser-based medical systems and devices for the treatment of glaucoma and retinal diseases. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and 70 distributors into 100 countries. Visit www.iridex.com.
Over the past 57 years, Kukje Pharma has succeeded in overcoming the limits and challenges of defeating diseases. Kukje took its first step as a prescription drug manufacturer 57 years ago. It is now Korea’s representative pharmaceutical company and continues further growth in becoming a global leader that will help render people around the world healthier. Kukje is committed to its vision of developing prescription drugs to prevent diseases as well as render your lives more meaningful and beautiful.
Designed for life-long control of severe or complex glaucoma, the effective and versatile Molteno3 S-Series implants are the culmination of fifty years of research and development.
MOLTENO Ophthalmic is bringing the Molteno3 S-Series implants to APGC 2018 so that participants can handle them and become familiar with their unique features.
QUANTEL MEDICAL, a French ophthalmic device manufacturer, offers a comprehensive product portofolio of diagnostic ultrasound and laser systems. Visit Quantel Medcical on booth A10 to discover SUPRA 810nm with Subliminal mode for subthreshold laser glaucoma treatment. Compact Touch UBM and Fusion YAG/SLT will also be showcased.
Reichert Technologies has been a global leader in the design and manufacture of high-quality diagnostic instruments and equipment for ophthalmologists, optometrists and retail eye care center for over 150 years. Reichert products are used for a wide range of applications, from common vision testing to diagnosing sight-threatening diseases.
Topcon is the leading company in eye care examination, diagnosis, and treatment. Today, it is applying ICT (Information Communication Technology) to eye care screening and prognostic management. In near future, big data analytics or AI diagnosis support will be reliable and realistic, where Topcon will also contribute to.
Sponsorship and exhibition opportunities for APGC 2018 are now available.
Further information about the industry sponsorship opportunities can be discussed with the sponsorship manager:
Sponsorship Development Manager
c/o MCI Australia
T: +61 2 9213 4016
E: [email protected]
If you are a current exhibitor, please click below to view important exhibition information for APGC 2018